Trial Profile
Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2018
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 15 Aug 2016 Status changed from recruiting to completed.
- 14 May 2015 New trial record